# ACVC

> ACVC is a VC fund in New York backing Biotechnology, Mobile and Genetics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 3
- Last investment: Jan 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.acvc.nyc/

ACVC is an early stage investment firm that focuses on millennial-driven tech opportunities across a variety of industries.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Mobile | 1 | 33% |
| Genetics | 1 | 33% |
| Software | 1 | 33% |
| Health Care | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Pre-Seed | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BreezeBio | GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. Thecompany's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling physicians to cure incurable genetic diseases. | $24M | Series A | Jan 23, 2024 |  |
| Elegen | Elegen is a biotechnology company that develops microfluidic technology. It is driven by a mission to deploy this technology in a new generation of DNA synthesizers aimed at enabling and accelerating biomedical advances. The company was founded in 2017 and led by Dr. Matthew Hill. |  | Series A | Dec 01, 2021 |  |
| Doorport | Doorport is designing software and hardware that is affordable for and adoptable by any multifamily building. Doorport's flagship product, Arrive installs at any building with no rewiring for a fraction of the upfront cost of traditional intercoms and access systems. | $500K | Pre-Seed | Apr 30, 2018 |  |

3 of 3 investments shown.

## Co-investors
- [8VC](https://shizune.co/investors/profile/8vc) — VC Fund, 1 deal together
- [Alix Ventures](https://shizune.co/investors/profile/alix-ventures) — VC Fund, 1 deal together
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 1 deal together
- [Blue Slide Ventures](https://shizune.co/investors/profile/blue-slide-ventures) — VC Fund, 1 deal together
- [Digitalis Ventures](https://shizune.co/investors/profile/digitalis-ventures) — VC Fund, 1 deal together
- [Dong-A ST](https://shizune.co/investors/profile/dong-a-st) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does ACVC invest in?

ACVC invests primarily in Biotechnology, Mobile and Genetics startups, most often at Series A and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did ACVC last invest?

The most recent investment recorded for ACVC closed in Jan 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co